Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-24

Clinical Trial Update: Combination Chemotherapy With or Without Metformin Hydrochloride in Treating Patients With Metastatic Pancreatic Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated adding metformin hydrochloride to chemotherapy for metastatic pancreatic cancer. The study was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • METFORMIN HYDROCHLORIDE (Metformin hydrochloride)

Snippet

Sponsor: IRCCS San Raffaele | Conditions: Pancreatic Cancer | Phase 2 | Status: TERMINATED